ClinicalTrials.govpublic full text
Efficacy and Safety of Two Hyperimmune Equine Anti Sars-CoV-2 Serum in COVID-19 Patients
covid19, covid-19, anti-sars-cov-2 equine immunoglobulin, passive immunotherapy, neutralizing equine antibodies., interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 834820
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.